Shenzhen FRD Science & Technology Co., Ltd.
SZSE:300602.SZ
18.26 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 4,345.941 | 4,124.511 | 3,058.009 | 2,929.339 | 2,615.271 | 1,325.763 | 1,036.41 | 842.978 | 647.176 | 605.887 | 458.975 | 392.678 |
Cost of Revenue
| 3,499.922 | 3,410.348 | 2,577.892 | 2,242.876 | 1,837.207 | 915.633 | 758.102 | 585.289 | 435.363 | 410.45 | 319.152 | 276.024 |
Gross Profit
| 846.019 | 714.163 | 480.116 | 686.462 | 778.064 | 410.129 | 278.309 | 257.689 | 211.813 | 195.437 | 139.823 | 116.654 |
Gross Profit Ratio
| 0.195 | 0.173 | 0.157 | 0.234 | 0.298 | 0.309 | 0.269 | 0.306 | 0.327 | 0.323 | 0.305 | 0.297 |
Reseach & Development Expenses
| 231.293 | 249.355 | 201.537 | 200.208 | 128.245 | 68.219 | 51.543 | 43.083 | 34.333 | 29.548 | 23.743 | 0 |
General & Administrative Expenses
| 106.385 | 121.828 | 89.097 | 81.817 | 87.971 | 66.504 | 18.296 | 15.076 | 13.81 | 15.471 | 13.174 | 45.663 |
Selling & Marketing Expenses
| 113.968 | 120.545 | 94.727 | 80.339 | 80.064 | 48.428 | 37.449 | 35.248 | 24.075 | 19.939 | 17.156 | 15.676 |
SG&A
| 220.353 | 242.373 | 183.824 | 162.157 | 168.035 | 114.931 | 55.746 | 50.324 | 37.885 | 35.41 | 30.33 | 61.338 |
Other Expenses
| 1.317 | -4.487 | -0.682 | 2.423 | 14.802 | -2.247 | 0.373 | 3.443 | 3.567 | 2.842 | 1.141 | 0.442 |
Operating Expenses
| 622.412 | 610.536 | 453.203 | 407.354 | 320.339 | 212.017 | 139.588 | 122.193 | 96.36 | 87.607 | 74.689 | 63.556 |
Operating Income
| 89.167 | 45.506 | -23.195 | 222.273 | 395.744 | 191.588 | 126.037 | 135.554 | 118.732 | 97.229 | 61.033 | 44.373 |
Operating Income Ratio
| 0.021 | 0.011 | -0.008 | 0.076 | 0.151 | 0.145 | 0.122 | 0.161 | 0.183 | 0.16 | 0.133 | 0.113 |
Total Other Income Expenses Net
| 1.317 | -4.487 | -0.682 | 2.423 | 14.802 | -2.247 | 0.373 | 3.351 | 3.151 | 2.769 | 0.785 | -0.132 |
Income Before Tax
| 90.485 | 41.02 | -23.878 | 224.696 | 410.546 | 189.341 | 126.41 | 138.905 | 121.883 | 99.998 | 61.818 | 44.241 |
Income Before Tax Ratio
| 0.021 | 0.01 | -0.008 | 0.077 | 0.157 | 0.143 | 0.122 | 0.165 | 0.188 | 0.165 | 0.135 | 0.113 |
Income Tax Expense
| 11.779 | -33.497 | 2.709 | 17.552 | 57.953 | 23.315 | 16.143 | 18.745 | 19.827 | 16.077 | 10.177 | 6.7 |
Net Income
| 103.214 | 96.187 | 30.094 | 208.891 | 350.756 | 162.459 | 108.148 | 115.888 | 100.749 | 83.921 | 50.366 | 37.848 |
Net Income Ratio
| 0.024 | 0.023 | 0.01 | 0.071 | 0.134 | 0.123 | 0.104 | 0.137 | 0.156 | 0.139 | 0.11 | 0.096 |
EPS
| 0.19 | 0.19 | 0.059 | 0.42 | 0.74 | 0.35 | 0.24 | 0.33 | 0.28 | 0.24 | 0.14 | 0 |
EPS Diluted
| 0.19 | 0.19 | 0.059 | 0.42 | 0.74 | 0.34 | 0.24 | 0.33 | 0.28 | 0.24 | 0.14 | 0 |
EBITDA
| 466.634 | 392.258 | 297.546 | 368.365 | 546.649 | 228.179 | 148.32 | 160.478 | 133.852 | 118.535 | 72.947 | 67.132 |
EBITDA Ratio
| 0.107 | 0.095 | 0.097 | 0.126 | 0.209 | 0.172 | 0.143 | 0.19 | 0.207 | 0.196 | 0.159 | 0.171 |